Exelixis, Inc. (EXEL)
NASDAQ: EXEL · Real-Time Price · USD
37.26
+1.04 (2.87%)
At close: Aug 1, 2025, 4:00 PM
37.47
+0.21 (0.56%)
After-hours: Aug 1, 2025, 4:29 PM EDT

CTI BioPharma Employees

Exelixis had 1,147 employees as of December 31, 2024. The number of employees decreased by 163 or -12.44% compared to the previous year.

Employees
1,147
Change (1Y)
-163
Growth (1Y)
-12.44%
Revenue / Employee
$1,944,207
Profits / Employee
$525,107
Market Cap
10.03B

Employees Chart

Employees History

DateEmployeesChangeGrowth
Dec 31, 20241,147-163-12.44%
Dec 31, 20231,310877.11%
Dec 31, 20221,22326928.20%
Dec 31, 202195418123.42%
Dec 31, 202077315625.28%
Dec 31, 201961713327.48%
Dec 31, 201848411230.11%
Dec 31, 20173728529.62%
Dec 31, 2016287172149.57%
Dec 31, 20151151717.35%
Dec 31, 201498-129-56.83%
Dec 31, 20132275330.46%
Dec 31, 2012174-26-13.00%
Dec 31, 2011200-183-47.78%
Dec 31, 2010383-293-43.34%
Dec 31, 20096760-
Dec 31, 2008676-59-8.03%
Dec 31, 20077358412.90%
Dec 31, 200665110118.36%
Dec 31, 2005550336.38%
Dec 31, 2004517-56-9.77%
Dec 31, 2003573234.18%
Dec 31, 2002550-21-3.68%
Dec 31, 200157121459.94%
Dec 31, 2000357--
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.